Related Experiment Videos
Depo-Provera in the treatment of recurrent vulvovaginal candidiasis
The Journal of Reproductive Medicine
|September 1, 1986
Abstract:
The long-acting injectable progestogen Depo-Provera appears to substantially reduce women's susceptibility to recurrent vulvovaginal candidiasis. Pregnancy and exogenous estrogen appear to counteract this effect of the drug. Evidence was derived from 15 patients studied for up to six years.
Keywords:
Bacterial And Fungal Diseases--prevention and controlBiologyClinical ResearchContraceptionContraceptive Agents, Female--administraction and dosageContraceptive Agents, Female--beneficial effectsContraceptive Agents, Progestin--administraction and dosageContraceptive Agents, Progestin--beneficial effectsContraceptive Agents--administraction and dosageContraceptive Agents--beneficial effectsDepo-provera--beneficial effectsDiseasesEndocrine SystemEstrogens--side effectsFamily PlanningHormonesInfections--prevention and controlMedroxyprogesterone Acetate--administraction and dosagePhysiologyReproductive Control AgentsResearch MethodologyTreatment